Before The Bell
FONT-SIZE Plus   Neg
Share SHARE

Medivation Inc. (MDVN) Jumped To A New High On Phase 3 Study Results

RELATED NEWS
Trade MDVN now with 

Medivation Inc. (MDVN: Quote) and Astellas Pharma Inc. announced positive results from the Phase 3 PREVAIL trial of enzalutamide after the bell Tuesday.

Medivation gapped open dramatically higher Wednesday, but traded in a range throughout the session. The stock finished up by 8.51 at $84.29 on above average volume. Medivation rose above a 2-week range and set a new high for the year.

Click here to receive FREE breaking news email alerts for MEDIVATION INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus